Worldwide, there are plants known as psychoactive plants that naturally contain psychedelic active components. They have a high concentration of neuroprotective substances that can interact with the nervous system to produce psychedelic effects. Despite these plants' hazardous potential, recreational use of them is on the rise because of their psychoactive properties. Early neuroscience studies relied heavily on psychoactive plants and plant natural products (NPs), and both recreational and hazardous NPs have contributed significantly to the understanding of almost all neurotransmitter systems. Worldwide, there are many plants that contain psychoactive properties, and people have been using them for ages. Psychoactive plant compounds may significantly alter how people perceive the world.
1. Cureus. 2024 Oct 2;16(10):e70681. doi: 10.7759/cureus.70681. eCollection 2024 Oct. The Problem to a Solution: A Case of Local Anesthetic-Related Acute Pancreatitis. Robles J(1), Rogando D(2), Ranjbar T(2), Mukherjee I(3), Clarke E(2), Mukharjee S(3). Author information: (1)Surgery, Northwell Health Staten Island University Hospital/City University of New York School of Medicine, New York, USA. (2)General Surgery, Northwell Health Staten Island University Hospital/City University of New York School of Medicine, New York, USA. (3)General Surgery, Northwell Health Staten Island University Hospital, New York, USA. Although rare, local anesthetic use has been associated with adverse central nervous system and cardiovascular adverse events. One complication is local anesthetic systemic toxicity (LAST), wherein the anesthetic agent inadvertently enters systemic circulation resulting in widespread inhibition of fast-gated sodium channels. Organs dependent on aerobic metabolism, such as the heart and brain, are especially susceptible to toxic injury resulting in cardiovascular collapse. Lipid emulsion therapy is a mainstay treatment of LAST; however, it may inadvertently cause lipid-induced necrotizing pancreatitis. We present a 71-year-old female with a non-contributory past medical history who presented for elective open reduction and internal fixation (ORIF) of the right wrist after a fall onto the right hand one week prior. A supraclavicular brachial plexus block was planned to deliver regional analgesia for ORIF of the right wrist. Shortly after the introduction of the local anesthetic agent, our patient became bradycardic and hypotensive. The patient's heart rate and systolic blood pressure remained in the low 45s and 50s, respectively, refractory to multiple doses of phenylephrine and ephedrine. Suspicion for LAST syndrome was high and lipid emulsion therapy was started. Once stabilized, the patient was transported to the ICU requiring manual ventilation, where she later reported flank pain. Labs drawn were notable for elevated triglyceride, lipase, and amylase levels of over 3000, 600, and 700, respectively. CT imaging confirmed acute necrotizing pancreatitis. The patient's ICU stay was uncomplicated with stabilization of vitals and discharge 10 days later. A follow-up with gastroenterology (GI) was scheduled after two weeks. Since discharge, the patient noted intermittent abdominal aches. Magnetic resonance cholangiopancreatography (MRCP) and MRI were performed after liver function tests (LFTs) were found to be elevated during her follow-up appointment. MRI showed liquefaction necrosis of 80% of the pancreas, with a 14-centimeter fluid collection pushing on the distal common bile duct, causing extrinsic obstruction. MRCP revealed no stones. Advanced GI performed a transgastric cystogastrostomy with lumen apposing metal stent placement in the common bile duct, and drained the fluid from the obstructing cyst. Cytopathology came back as virtually acellular. Liver enzymes began to downtrend appropriately and the patient was discharged soon after. Follow-up at two and four days post-discharge confirmed resolution of symptoms. Copyright © 2024, Robles et al. DOI: 10.7759/cureus.70681 PMCID: PMC11528620 PMID: 39493173 Conflict of interest statement: Human subjects: Consent was obtained or waived by all participants in this study. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work. 2. J Perianesth Nurs. 2024 Nov 1:S1089-9472(24)00391-5. doi: 10.1016/j.jopan.2024.07.023. Online ahead of print. Preventing Spinal-induced Hypotension During Elective Cesarean Sections. Rowe N(1), Calhoun K(2), Oliver K(2), Wofford K(2), Canale M(2). Author information: (1)College of Nursing, University of South Florida, Tampa, FL. Electronic address: hoyt16@usf.edu. (2)College of Nursing, University of South Florida, Tampa, FL. PURPOSE: The purpose of this quality improvement project was to implement an evidence-based intraoperative protocol to reduce the incidence of spinal-induced hypotension during elective cesarean sections. DESIGN: A quality improvement project. METHODS: After receiving education, anesthesia providers implemented the intraoperative protocol for 6 weeks on elective cesarean sections. Intraoperative anesthesia records were retrospectively reviewed and evaluated preimplementation and postimplementation to determine the impact of the project on the incidence of spinal-induced hypotension. FINDINGS: The final sample included 134 patient charts (64 preimplementation and 72 postimplementation). The incidence of hypotension 10 minutes after spinal placement was not significantly different before (n = 9) or after implementation (n = 13; χ2 = 0.4, P = .554). After project implementation, the rate of hypotension was 22% (n = 13) in patients not treated per the protocol and 0% (n = 0, χ2 = 3.5, P = .062) in patients treated per the protocol. There was a 39.4% (P < .001) reduction in the need for rescue doses of phenylephrine and a 27.8% (P = .001) reduction in the need for rescue doses of ephedrine after protocol implementation. CONCLUSIONS: Hypotension was not significantly decreased for all patients after project implementation but was eliminated for patients in whom the protocol was used. Provider utilization of the intraoperative protocol was only 18%. It is recommended to pursue additional interventions to increase protocol utilization, accessibility of protocol components, and staff training. Future studies can investigate the impact of this protocol on maternal nausea and vomiting incidence during elective cesarean sections. Copyright © 2024 The American Society of PeriAnesthesia Nurses. Published by Elsevier Inc. All rights reserved. DOI: 10.1016/j.jopan.2024.07.023 PMID: 39488780 Conflict of interest statement: Declaration of Competing Interest None to report. 3. Sci Rep. 2024 Nov 2;14(1):26443. doi: 10.1038/s41598-024-77785-w. Late pleistocene exploitation of Ephedra in a funerary context in Morocco. Morales J(1), Carrión Marco Y(2)(3), Cooper JH(4), Turner E(5), Freyne A(6), Hogue J(7)(8), Ziani I(2), Barton RNE(7), Bouzouggar A(9)(10), Humphrey LT(2). Author information: (1)Research Group Tarha, Department of Historical Sciences, University of Las Palmas de Gran Canaria, Pérez del Toro 1, Las Palmas, 35003, Spain. jacob.morales@ulpgc.es. (2)Research Group Tarha, Department of Historical Sciences, University of Las Palmas de Gran Canaria, Pérez del Toro 1, Las Palmas, 35003, Spain. (3)Departamento de Prehistoria, Arqueología e Historia Antigua, PREMEDOC, Universidad de Valencia, Valencia, Spain. (4)Bird Group, The Natural History Museum, Akeman Street, Tring, HP23 6AP, Hertfordshire, UK. (5)Monrepos Archaeological Research Centre and Museum for Human Behavioural Evolution, Leibniz- Zentrum für Archäologie, Schloss Monrepos, D-56567, Neuwied, Germany. (6)Centre for Human Evolution Research, Natural History Museum, Cromwell Road, London, SW7 5BD, UK. (7)Institute of Archaeology, Oxford University, Oxford, OX1 2PG, UK. (8)Allen Archaeology Ltd, Whisby Lodge, Lincoln, LN6 3QL, UK. (9)Institut National des Sciences de l'Archéologie et du Patrimoine, group leader Origin and Evolution of Homo sapiens cultures in Morocco, Av. Allal El Fassi angle rues 5 et 7,Madinat Al Irfane, Hay Riad, Rabat, Morocco. (10)Department of Archaeogenetics, Max Planck Institute for Evolutionary Anthropology, Leipzig, Germany. The active compounds found in many plants have been widely used in traditional medicine and ritual activities. However, archaeological evidence for the use of such plants, especially in the Palaeolithic period, is limited due to the poor preservation and fragility of seed, fruit, and other botanical macro-remains. In this study, we investigate the presence and possible uses of Ephedra during the Late Pleistocene based on the analysis of exceptionally preserved plant macrofossils recovered from c. 15 ka year-old archaeological deposits at Grotte des Pigeons in northeastern Morocco. This cave has yielded the earliest carbonized plant macrofossils of Ephedra, which were found concentrated in a human burial deposit along with other special finds. Ephedra is a plant known to produce high amounts of alkaloids, primarily ephedrine and pseudoephedrine, which have been utilized in traditional medicine. Direct radiocarbon dates on both Ephedra and the human remains indicate that they were contemporaneous. To understand the uses of Ephedra by people at the site, we discuss the different pathways through which plant remains could have arrived. We suggest that the charred cone bracts of Ephedra likely represent residues of the processing and consumption of the plant's fleshy cones, which may have been valued for both their nutritional and therapeutic properties. Furthermore, we interpret the presence of Ephedra and its deposition in the burial area as evidence that this plant played a significant role during the funerary activities. © 2024. The Author(s). DOI: 10.1038/s41598-024-77785-w PMCID: PMC11531600 PMID: 39488593 [Indexed for MEDLINE] Conflict of interest statement: The authors declare no competing interests. 4. BMC Anesthesiol. 2024 Oct 30;24(1):394. doi: 10.1186/s12871-024-02779-0. Efficacy and safety of esketamine combined with propofol for conscious sedation in painless colonoscopy: a prospective, randomized, double-blind controlled clinical trial. Xiao L(1), Zhang Z(1), Lu J(1), Liu Z(1), Zhang J(1), Kang L(1), Tang J(2), Zou X(3). Author information: (1)Department of Anesthesiology, First Affiliated Hospital of Hunan University of Medicine, Huaihua City, Hunan Province, China. (2)Department of Anesthesiology, First Affiliated Hospital of Hunan University of Medicine, Huaihua City, Hunan Province, China. tangjiefu@126.com. (3)Department of Anesthesiology, Affiliated Hospital of Guizhou Medical University, Guiyang City, Guizhou Province, China. zouxiaohuazxh@163.com. BACKGROUND: We explored the efficacy and safety of esketamine combined with propofol for conscious sedation in painless colonoscopy. METHODS: A total of 195 patients who underwent painless colonoscopy surgery were randomly divided into three groups: the propofol deep sedation group (group DS), the sufentanil combined with propofol for conscious sedation (group CS1) and the esketamine combined with propofol for conscious sedation (group CS2). The primary outcomes of this study included the incidence of hypoxemia, hypotension, hypertension, and bradycardia and excellent and good rates of anaesthesia during colonoscopy. The secondary outcomes included perioperative changes in vital signs (MAP, HR, and SpO2), anaesthesia induction time, dischargeable time, patient and endoscopist satisfaction scores, and incidence of postoperative nausea and vomiting (PONV), drowsiness, dizziness, propofol injection pain, assisted ventilation and vasoactive medications. RESULTS: The incidence of intraoperative hypoxemia in the DS group was significantly greater than that in the CS1 and CS2 groups (χ2 = 7.081, P = 0.029). The incidence of hypotension in the CS2 group was significantly lower than that in the DS and CS1 groups (χ2 = 16.278, P < 0.001). The risk of hypoxemia was 5.727 times higher in Group DS than in Group CS2 (OR 5.727; 95%CI 1.203-27.273), and the risk of hypotension was 9.864 times higher in Group DS than in Group CS2 (OR 9.864; 95%CI 2.770-35.120). The risk of hypotension in Group CS1 was 5.167 times that in Group CS2 (OR 5.167; 95%CI 1.396-19.117). The incidence of propofol injection pain, assisted ventilation, ephedrine usage and drowsiness in the DS group was significantly greater than that in the CS1 and CS2 groups (χ2 = 57.618, P < 0.001; χ2 = 9.544, P = 0.008; χ2 = 14.820, P = 0.001; χ2 = 37.257, P < 0.001). The incidence of dizziness during recovery in the CS1 group was significantly greater than that in the DS and CS2 groups (χ2 = 6.594, P = 0.037). The dischargeable time in the DS group was significantly greater than that in the CS1 and CS2 groups (F = 53.039, P < 0.001). The satisfaction scores of the endoscopist and patients in the DS group were significantly lower than those in the CS1 and CS2 groups (F = 17.390, P < 0.001; F = 19.282; P < 0.001). CONCLUSIONS: In conclusion, esketamine combined with propofol for conscious sedation can be safely and effectively used for painless colonoscopy and has fewer complications.It is recommended for painless colonoscopy. © 2024. The Author(s). DOI: 10.1186/s12871-024-02779-0 PMCID: PMC11523800 PMID: 39478485 [Indexed for MEDLINE] Conflict of interest statement: The authors declare no competing interests. 5. J Nat Med. 2024 Oct 29. doi: 10.1007/s11418-024-01853-8. Online ahead of print. Preventive and therapeutic effects of ephedrine alkaloids-free Ephedra Herb extract on paclitaxel-induced neuropathic pain. Huang X(1), Hyuga S(2), Ito M(3), Goda Y(3), Kobayashi Y(1). Author information: (1)Oriental Medicine Research Center, School of Pharmacy, Kitasato University, Tokyo, Japan. (2)Oriental Medicine Research Center, School of Pharmacy, Kitasato University, Tokyo, Japan. hyuga-s@insti.kitasato-u.ac.jp. (3)National Institute of Health Sciences, Kawasaki, Japan. Currently, there are no effective prophylactic or therapeutic drugs for the treatment of paclitaxel (PTX)-induced peripheral neuropathic pain (PTX-PNP), highlighting the urgent need for the development of effective prophylactic and therapeutic drugs. In this study, we initially compared the efficacy of Ephedra Herb extract (EHE) with that of ephedrine alkaloids-free Ephedra Herb extract (EFE), which lacked ephedrine alkaloids (EAs)-associated side effects, against the onset of PTX-induced mechanical allodynia, thermal hyperalgesia, and cold allodynia in mice. EHE and EFE demonstrated comparable preventive effects on the PTX-PNP in a dose-dependent manner. These results indicated that the preventive properties of EHE were independent of the EAs. Since elderly people are overwhelmingly more susceptible to developing cancer, we considered that EFE has greater benefits than EHE, so we conducted a study focused on the effects of EFE. EFE showed dose-dependent preventive effects on the onset of PTX-PNP. As a result of detailed investigation, coadministration of PTX and EFE (Co-EFE) was more effective than preadministration of EFE alone (Pre-EFE). And the effects of Co-EFE was same with the effect of preadministration of EFE and then coadministration of PTX and EFE (P&C-EFE). Additionally, Co-EFE after the onset of PTX-PNP improved PTX-induced mechanical allodynia, thermal hyperalgesia, and cold allodynia, confirming the therapeutic efficacy of EFE on PTX-PNP. In contrast, goshajinkigan, a Kampo medicine, and diclofenac, a non-steroidal anti-inflammatory drug, showed minimal therapeutic effects on PTX-PNP. These findings demonstrate the significant potential of EFE as a novel, safe prophylactic and therapeutic agent against PTX-PNP. © 2024. The Author(s) under exclusive licence to The Japanese Society of Pharmacognosy. DOI: 10.1007/s11418-024-01853-8 PMID: 39470960